Literature DB >> 8700535

Induction of apoptosis by the tumor suppressor protein BRCA1.

N Shao1, Y L Chai, E Shyam, P Reddy, V N Rao.   

Abstract

The breast and ovarian cancer susceptibility gene BRCA1, is a nuclear phosphoprotein which functions as a tumor suppressor. To investigate the role of BRCA1 in apoptosis, we have developed mouse fibroblast cell lines and human breast cancer cell lines expressing BRCA1. The expression of BRCA1 protein in the BRCA1 transfectants were analysed by immunofluorescence and immunohistochemistry. The BRCA1 transfectants showed a flattened morphology compared to the parental cells. We show that serum deprivation or calcium ionophore treatment of BRCA1 transfectants resulted in programmed cell death. These results indicate that BRCA1 genes may play a critical role in the regulation of apoptosis. Thus, since a wide variety of human malignancies like breast and ovarian cancers have a decreased ability to undergo apoptosis, this could be due to lack/decreased levels of functional BRCA1 proteins. Treatments that are aimed at increasing the apoptotic threshold by BRCA1 gene therapy may have the potential to prevent the progression of these malignancies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8700535

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

1.  BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site.

Authors:  H Ruffner; W Jiang; A G Craig; T Hunter; I M Verma
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

Review 2.  BRCA1 and BRCA2 proteins: roles in health and disease.

Authors:  J A Duncan; J R Reeves; T G Cooke
Journal:  Mol Pathol       Date:  1998-10

3.  BRCA1 partially reverses the transforming activity of the ras oncogene.

Authors:  A Kumar; C Knott; K Kuus-Reichel; M S Saedi
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

Review 4.  Emerging roles of BRCA1 alternative splicing.

Authors:  T I Orban; E Olah
Journal:  Mol Pathol       Date:  2003-08

5.  BRCA1 is associated with the centrosome during mitosis.

Authors:  L C Hsu; R L White
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

6.  BRCA1 is a cell cycle-regulated nuclear phosphoprotein.

Authors:  H Ruffner; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

7.  Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins.

Authors:  Anna W Maniccia; Catherine Lewis; Nurjahan Begum; Jingyao Xu; Jianqi Cui; Galina Chipitsyna; Kartik Aysola; Vaishali Reddy; Ganapathy Bhat; Yasuo Fujimura; Beric Henderson; E Shyam P Reddy; Veena N Rao
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

8.  The BRCA1 tumor suppressor binds to inositol 1,4,5-trisphosphate receptors to stimulate apoptotic calcium release.

Authors:  Serena C Hedgepeth; M Iveth Garcia; Larry E Wagner; Ana M Rodriguez; Sree V Chintapalli; Russell R Snyder; Gary D V Hankins; Beric R Henderson; Kirsty M Brodie; David I Yule; Damian B van Rossum; Darren Boehning
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

9.  BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells.

Authors:  P Tassone; P Tagliaferri; A Perricelli; S Blotta; B Quaresima; M L Martelli; A Goel; V Barbieri; F Costanzo; C R Boland; S Venuta
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

10.  Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas.

Authors:  Katherine V Clark-Knowles; Mary K Senterman; Olga Collins; Barbara C Vanderhyden
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.